Note: Ingredients listed on restricted chemical lists
EC/CAS
91-20-3
Name of the chemical
Naphthalene,3
Concentration
N/A
General Information
Revision date
2006-09-08
Product name
ENVOY Plus Herbicide
Product Synonyms
None
Manufacturer Name
VALENT USA CORPORATION
Emergency telephone
HEALTH EMERGENCY OR SPILL (24 hr
Icons in SDS
Company Information
company name
VALENT USA CORPORATION
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW CAUTION • May cause moderate eye irritation. • May cause skin and respiratory irritation. • Prolonged or frequently repeated skin contact may cause allergic reactions in some individuals. • Harmful if swallowed.
Aspiration hazard
do not induce vomiting • Combustible. • Avoid breathing vapors or spray mist. • Avoid contact with eyes, skin and clothing. • Keep out of reach of children.
Potential health effects
Acute Toxicity (Primary Routes of Exposure) Signs and Symptoms of Systemic Effects: This product contains a solvent mixture. Solvents, when inhaled, can cause nasal and respiratory irritation and central nervous system effects including dizziness, weakness, fatigue, nausea, headache and possibly unconsciousness and even death. Ingestion of solvents can cause gastrointestinal irritation, nausea, vomiting and diarrhea. Aspiration of low viscosity solvents can cause chemical pneumonitis which can be fatal. Acute exposure to naphthalene by inhalation, ingestion, and dermal contact has been associated with hemolytic anemia, damage to the kidneys, cataracts, and, in infants, brain damage. Acute Eye Contact: This product is a moderate eye irritant. Adverse health effects resulting from an exposure may include redness, swelling and pain which could last for an extended period of time. Acute Skin Contact: This product can cause moderate skin irritation. The expected adverse health effects resulting from an exposure may include redness and swelling. This product is minimally toxic when absorbed through the skin. This product may cause allergic skin reactions. In sensitized individuals even small exposures can trigger allergic reactions. The expected adverse health effects may include itching, redness, swelling and blistering of the skin. Acute Ingestion: This product is minimally toxic when ingested. Because of the low viscosity of this substance, it can directly enter the lungs if it is swallowed (this is called aspiration). This can occur during the act of swallowing or when vomiting the substance. Once in the lungs, the substance is very difficult to remove and can cause injury to the lungs and death. Acute Inhalation: This product is minimally toxic when inhaled. Chronic Toxicity (including cancer): Increased liver weights and anemia have been observed in animals exposed to Clethodim Technical. Clethodim Technical was not carcinogenic to animals. Prolonged or repeated dermal exposures may cause drying, scaling and even blistering of the skin. Reports have associated repeated and prolonged occupational overexposure to solvents with permanent brain and nervous system damage. Symptoms include fatigue, concentration difficulties, anxiety, depression, rapid mood swings and short-term memory loss. The reports are not clear with regard to the types of solvents that may cause these symptoms, and there is controversy among scientists to whether the condition exists or is caused by this type of product. Since many other diseases cause some or all of these conditions, a doctor should be consulted if any appear. This product contains naphthalene which has been listed by the International Agency for Research on Cancer (IARC) as possibly carcinogenic to humans (Group 2B). Developmental Toxicity (birth defects): Clethodim Technical produced developmental toxicity only at maternally toxic dose levels. It is not expected to present a hazard under normal use conditions. There is limited evidence of fetal and maternal toxicity from exposure to naphthalene. Reproductive Toxicity: No reproductive toxicity was observed in animals exposed to Clethodim Technical. Potentially Aggravated Medical Conditions: Individuals with preexisting diseases of the liver, red blood cell or central nervous system may have increased susceptability to the toxicity of excessive exposures. For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Regulatory Information, refer to Section 15.